Postmarketing surveillance of new food ingredients: Results from the program with the fat replacer olestra

Gregory S. Allgood, David J. Kuter, Kevin T. Roll, Steve L. Taylor, Nora L. Zorich

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Market introduction of savory snacks containing olestra offered an opportunity to evaluate the safety of olestra in a free-living population and thereby compare the outcome to the previously established safety profile determined in clinical trials in which subjects were required to eat predetermined amounts at prescribed intervals. Therefore, a multifaceted postmarketing surveillance program was designed to evaluate consumer experience and safety of olestra in the marketplace. Customer comments were solicited through toll-free telephone numbers. Collected data were evaluated by both internal and external medical experts. About 10% of toll-free telephone calls reported health effects, most of which were gastrointestinal (GI) in nature. Clinical studies were designed and conducted to determine potential GI effects under the range of consumption patterns reported by toll-free calls. Health effects reported were those found commonly in the general population and analyses of the data found no biological reason to conclude that serious or meaningful health effects were the result of olestra consumption.

Original languageEnglish (US)
Pages (from-to)224-233
Number of pages10
JournalRegulatory Toxicology and Pharmacology
Volume33
Issue number2
DOIs
StatePublished - Apr 2001

Keywords

  • Allergy
  • Fat consumption
  • Fat substitute
  • Gastrointestinal
  • Olean
  • Olestra
  • Postmarketing surveillance
  • Procter & Gamble
  • Vitamin K
  • Warfarin

ASJC Scopus subject areas

  • Toxicology

Fingerprint Dive into the research topics of 'Postmarketing surveillance of new food ingredients: Results from the program with the fat replacer olestra'. Together they form a unique fingerprint.

  • Cite this